Janiczek Wealth Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
$444K Sell
5,630
-1,137
-17% -$93.2K 0.09% 90
2024
Q1
$590K Buy
6,767
+3,845
+132% +$328K 0.13% 77
2023
Q4
$241K Sell
2,922
-3,875
-57% -$295K 0.06% 136
2023
Q3
$533K Sell
6,797
-609
-8% -$51K 0.14% 61
2023
Q2
$653K Buy
7,406
+488
+7% +$42K 0.18% 43
2023
Q1
$558K Buy
6,918
+1,641
+31% +$134K 0.16% 46
2022
Q4
$422K Buy
5,277
+1,488
+39% +$121K 0.12% 60
2022
Q3
$311K Buy
3,789
+712
+23% +$64K 0.1% 66
2022
Q2
$285K Sell
3,077
-622
-17% -$63K 0.08% 76
2022
Q1
$411K Buy
3,699
+1,819
+97% +$192K 0.11% 59
2021
Q4
$194K Sell
1,880
-1,271
-40% -$147K 0.06% 110
2021
Q3
$395K Buy
3,151
+798
+34% +$103K 0.14% 50
2021
Q2
$292K Buy
2,353
+678
+40% +$85.1K 0.11% 57
2021
Q1
$198K Buy
1,675
+403
+32% +$47.2K 0.08% 70
2020
Q4
$149K Buy
1,272
+1,045
+460% +$115K 0.07% 79
2020
Q3
$24K Buy
227
+92
+68% +$9.24K 0.01% 146
2020
Q2
$12K Buy
+135
New +$12.9K 0.01% 139

Other funds holding MDT

Janiczek Wealth Management's MDT Position: Q2 2024 in Review

Janiczek Wealth Management reduced its Medtronic (MDT) stake by 17% in Q2 2024, selling an estimated $93.2K and leaving 5,630 shares worth $444K. The position accounts for 0.09% of the portfolio, ranked #90.

Janiczek Wealth Management first reported a position in MDT in Q2 2020 and has held it in 17 quarters since. The position peaked at $653K in Q2 2023. 2,023 funds tracked by Wall St. Rank hold MDT as of Q2 2024.

  • Janiczek Wealth Management held 5,630 shares of Medtronic worth $444K as of Q2 2024.
  • Janiczek Wealth Management sold 1,137 Medtronic shares in Q2 2024, an estimated $93.2K.
  • Medtronic made up 0.09% of Janiczek Wealth Management's portfolio in Q2 2024, its #90 holding.
  • Janiczek Wealth Management first reported a position in Medtronic in Q2 2020 and has held it in 17 quarters since.
  • Janiczek Wealth Management's Medtronic position peaked at $653K in Q2 2023.
  • 2,023 funds tracked by Wall St. Rank held Medtronic as of Q2 2024.

Based on Janiczek Wealth Management's 13F filing for Q2 2024, filed 25 Jul 2024.